Guest Blogs - Page 15 of 38 - Express Pharma

Conservation of endangered medicinal species “Picrorhiza kurroa”

Navigating Section 194R with respect to pharma business organisations and way forward

India can continue to be number one in generic pharma business

Emerging opportunities in EU generics market

Centre appoints high-level committee to examine pharma marketing of drugs

Advanced antibodies will revolutionise the future of Immuno-Oncology (IO)

Raw material prices affect margins of pharma drugs

Digital transformation and emerging opportunities

FSP model in clinical research industry: A natural progression and synergistic approach for FSO delivery gap mitigations for niche clinical studies and services

Challenges and strategies for rare diseases trials in India